SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending after announcing a 75 million-share public offering to raise approximately $1.5 billion, sparking a sharp decline as investors react to the dilution. While community sentiment is heavily polarized, the primary debate focuses on whether this capital raise is a necessary move to unlock government loan funding for factory expansion or a poorly timed decision that undermines recent stock momentum.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is facing heightened volatility and selling pressure following a patent infringement lawsuit filed by Wolfspeed, which has triggered community debate over the company's long-term competitive position and legal risks. Investors are sharply divided between those viewing the pullback as a buying opportunity based on the stock's role in AI data center power infrastructure and others cautioning against overvaluation and potential dilution.

Penguin Solutions, Inc. engages in designing, building, and managing enterprise solutions. It operates through the following segments: Advanced Computing, Integrated Memory, and Optimized LED. The Advanced Computing segment offers platform solutions and services for artificial intelligence, high-performance computing, machine learning, advanced modeling, and the internet of things. The Integrated Memory refers to integrated memory solutions through the design and development. The Optimized LED segment comprises a broad portfolio of application-optimized LEDs. The company was founded in 1988 and is headquartered in Fremont, CA.

Penguin Solutions Inc.

Penguin Solutions is gaining significant attention following a strong earnings beat and raised guidance, fueled by robust demand for its AI infrastructure and integrated memory solutions. The community is actively debating the stock's potential as an AI factory partner versus concerns regarding its memory-focused business model and potential share dilution.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst Pharmaceuticals is seeing significant market interest driven by potential buyout speculation and a shift toward a more capital-efficient model following the closure of its internal discovery laboratory. The community is actively debating the likelihood of an M&A catalyst, with traders closely tracking short interest and technical breakouts as they look for sustained momentum toward higher price levels.

Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The firm's product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly. It is also developing other oral nonpeptide somatostatin agonists for neuroendocrine tumors and hyperinsulinism, as well as an oral nonpeptide ACTH antagonist for the treatment of Cushing's disease. The company was founded by R. Scott Struthers, Yun-Fei Zhu and Stephen F. Betz in 2008 and is headquartered in San Diego, CA.

Crinetics Pharmaceuticals Inc

Crinetics Pharmaceuticals is trending after Vertex Pharmaceuticals announced a definitive agreement to acquire the company for $10 billion in an all-cash deal. The community is actively discussing the massive valuation premium and the strategic validation the acquisition provides for the broader rare endocrine and obesity therapeutic landscape.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways is surging following positive Phase 3 clinical data for its COMP360 psilocybin treatment, which demonstrates rapid and durable efficacy in patients with treatment-resistant depression. The community is actively discussing the stock's potential for FDA approval and eventual buyout, with many traders emphasizing the company's strong cash position and its role as a first-mover in the high-stakes psychedelic medicine sector.

FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCell Energy is trending as investors react to a significant share offering aimed at funding manufacturing expansion for the growing AI data center power market. While some in the community view the capital raise as a necessary step to scale operations and meet rising demand, many retail shareholders are expressing frustration over the dilutive impact on their positions and the company's long-term performance history.

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Vertex Pharmaceuticals, Inc.

Vertex Pharmaceuticals is trending following the major ten billion dollar all-cash acquisition of Crinetics Pharmaceuticals, a strategic move that significantly expands its pipeline into the rare endocrine and obesity landscape. Community discussion is heavily focused on how this deal serves as a broader validation for the sector's growth potential while prompting investors to reassess the company's long-term valuation alongside its existing robust clinical pipeline.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

NuScale Power is capturing significant investor attention as market participants weigh its role in the AI-driven energy sector against the challenges of project execution and dilution. While some community members remain frustrated by the lack of immediate contract announcements, many are actively debating the stock's potential for a major technical rebound if it successfully secures anticipated partnerships or government-backed funding.

One Stop Systems, Inc. engages in the design, manufacture, and marketing of computing modules and systems targeting edge deployments. It deals with the design and manufacture of high-performance customized computer and flash arrays, in-flight entertainment, and connectivity and value-added reseller with minimal customization. The company operates through the OSS and OSS Europe segments. One Stop Systems was founded by Stephen D. Cooper and Mark Gunn in 1998 and is headquartered in Escondido, CA.

One Stop Systems Inc

One Stop Systems is trending due to the convergence of its rugged edge AI hardware being positioned as a key component for defense and autonomous systems, alongside bullish community sentiment regarding potential index inclusion and upcoming contract catalysts. Investors are actively discussing the stock's role in the physical AI buildout and debating whether current pullbacks represent a strategic buying opportunity or a broader sector rotation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$TLS I’m even on this but bought more today. Looks like it may turn around on next earnings but needs to pass resistance too

Mike

StockTwits for iOS

Telos Corp

 I’m even on this but bought more today. Looks like it may turn around on next earnings but needs to pass resistance too